Quest Laboratories (QUESTLAB.NS) Osake Kurssi

Quest Laboratories Ltd is an Indian pharmaceutical manufacturer headquartered in Dhar, Madhya Pradesh, which listed its shares on the stock exchange on 23 May 2024. The company produces a wide range of pharmaceutical formulations, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, and antidepressants. Its product portfolio encompasses ethical drugs, generic medicines, and over-the-counter items, available in diverse forms such as tablets, liquid orals, oral dry powders, oral rehydration salts, ointments, and external liquids. Specific offerings include Cetirizine Hydrochloride and Diclofenac Sodium tablets, as well as Ferrous Sulphate & Folic Acid syrup and Albendazole suspension. The firm also manufactures Silver Sulphadiazine cream and Diclofenac Diethylamino gel. By manufacturing these varied therapeutic agents, Quest Laboratories serves the domestic healthcare market with a focus on accessible and essential medicinal products. The company’s operations are centered on the production and distribution of these critical health care solutions within India.